EATON VANCE MANAGEMENT – Neurocrine Biosciences, Inc. Transaction History
EATON VANCE MANAGEMENT portfolio value:
$143.15M
portfolio value
EATON VANCE MANAGEMENT quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -8.29% | -121.79K shares | -106K | $106.21 | 1.34M |
| Q2 2022 | share | Increase | +0.93% | 13.56K shares | 6.75M | $97.48 | 1.46M |
| Q1 2022 | share | Decrease | -21.16% | -390.86K shares | -20.79M | $93.75 | 1.45M |
| Q4 2021 | share | Decrease | -2.07% | -38.99K shares | -23.95M | $84.63 | 1.84M |
| Q3 2021 | share | Increase | +52.94% | 652.77K shares | 61.23M | $95.91 | 1.88M |
| Q2 2021 | share | Increase | +51.04% | 416.71K shares | 40.61M | $97.32 | 1.23M |
| Q1 2021 | share | Increase | +54.48% | 287.92K shares | 28.74M | $97.25 | 816.41K |
| Q4 2020 | share | Increase | +310.78% | 399.83K shares | 38.28M | $95.85 | 528.48K |
| Q3 2020 | share | 0.00% | 0 shares | -3.32M | $96.16 | 128.65K | |
| Q2 2020 | share | 0.00% | 0 shares | 4.56M | $122 | 128.65K | |
| Q1 2020 | share | Increase | +9.01% | 10.63K shares | -1.55M | $86.55 | 128.65K |
| Q4 2019 | share | Decrease | -11.94% | -16.00K shares | 609K | $107.49 | 118.02K |
| Q3 2019 | share | 0.00% | 0 shares | 761K | $90.11 | 134.02K | |
| Q2 2019 | share | Decrease | -17.77% | -28.97K shares | -3.04M | $84.43 | 134.02K |
| Q1 2019 | share | Increase | +25.93% | 33.56K shares | 5.11M | $88.1 | 163.00K |
| Q4 2018 | share | Increase | +20.79% | 22.28K shares | -3.93M | $71.41 | 129.43K |
| Q3 2018 | share | Increase | +34.24% | 27.33K shares | 5.33M | $122.95 | 107.15K |
| Q2 2018 | share | Increase | +46.53% | 25.34K shares | 3.32M | $98.24 | 79.82K |
| Q1 2018 | share | Increase | +172.37% | 34.47K shares | 2.96M | $82.93 | 54.47K |
| Q4 2017 | share | Increase | 0.00% | 20K shares | 1.55M | $77.59 | 20K |